You are here: Home » Companies » News
Business Standard

Sun Pharma net profit up 31% at Rs 1,387 cr in June quarter of FY20

The company had posted a profit of Rs 1,057.29 crore for the corresponding period of the previous fiscal, Sun Pharma said in a filing to BSE

Press Trust of India  |  New Delhi 

Sun Pharma Founder and Managing Director Dilip Shanghvi said the company would grow its speciality drug pipeline globally and expand manufacturing facilities
Sun Pharma

Sun Pharmaceutical Industries on Tuesday reported a consolidated net profit of Rs 1,387.48 crore for the quarter ended June 30, 2019.

The company had posted a profit of Rs 1,057.29 crore for the corresponding period of the previous fiscal, Sun Pharma said in a filing to BSE.

Total revenue from operations for the quarter under review stood at Rs 8,374.36 crore. It was Rs 7,224.17 crore for the same period a year ago.

"Pola Pharma lnc Japan became a step-down subsidiary of the company with effect from January 1, 20l9. Accordingly, the results for the quarter include results of Pola Pharma Inc, and hence are not comparable with quarter ended June 30, 2018," the company said.

Shares of Sun Pharmaceutical Industries were trading at Rs 441 per scrip on BSE, up 4.53 per cent from the precious close.

First Published: Tue, August 13 2019. 15:55 IST
RECOMMENDED FOR YOU